Clinteligent Announces New Partnership Agreement With MEDai, Inc.; Clinteligent Delivers MEDai Technology as a Part of Its Application Services Provider Business Model.

SAN DIEGO--(BW HealthWire)--Sept. 17, 1999--

Clinteligent(TM), a wholly owned subsidiary of CliniComp, Intl., today announced that it has entered into a partnership to include the products of MEDai, Inc.(R) (Medical Artificial Intelligence) in its application service offerings.

MEDai's solutions enable healthcare organizations to measure disease severity and demonstrate the correlation between clinical outcomes and patient financial information. Adding the data derived from point-of-care charting to the hospital charge information that is traditionally used for outcomes measurement and decision support creates a new level of comprehensive clinical information. This information provides the framework for MEDai's technology to provide clinical decision-support that improves the quality and cost of treating patients. In addition to MEDai, Clinteligent offers CliniComp's inpatient and outpatient point-of-care modules, an enterprise-wide clinical data repository (CDR) as well as the NextGen ambulatory electronic medical record.

Clinteligent delivers its services under an application services provider (ASP) model, so healthcare organizations can select the clinical information services they need where they need them, regardless of geographic location. Organizations pay a monthly fee to access the services they need, versus incurring large, up-front capital expenses for licensing, equipment and implementation fees. The ASP model decreases the cost of clinical computing and seamlessly integrates software applications throughout the healthcare enterprise.

"We are intrigued with Clinteligent's quick, cost-effective method that allows healthcare organizations to benefit from online, real-time, high-level clinical information systems," said Andrew Larkowich, MEDai's chief operating officer. "MEDai's superior accuracy combined with Clinteligent's business model will open the door for healthcare organizations of all sizes to benefit from our technology, from the largest integrated delivery network to the smallest rural clinic."

Combined with information gathered by Clinteligent's systems, MEDai's solutions will use automated tools to turn information into intelligence, such as intelligent data clean up, clinical decision-support, provider profiling, high-risk prediction, clinical indicators, and disease analysis. For example, one of MEDai's technologies examines a health provider's claims data, medical records information and other healthcare data to identify which individuals within a patient population are likely to develop severe medical problems over a specific period of time, and predict the associated cost of treatment. When providers can ascertain which of their patients are likely to develop chronic illnesses, interventions can be made to lessen the severity or prevent its development altogether.

"MEDai, Inc. is recognized as a pioneer in the development of data mining techniques that measure and predict outcomes, and their processes produce results with accuracy beyond that of all other commercial methodologies," said Chris Haudenschild, founder, president and chief executive officer of Clinteligent. "Combining MEDai's expertise in the field of artificial intelligence and our clinical information system track record, healthcare organizations will be able to better leverage patient data more than ever before to improve care and increase profitability."

About MEDai, Inc.

MEDai, Inc. is a privately held corporation located in Orlando, FL. The company began operations in 1988 and was incorporated in 1992. MEDai, Inc., widely acknowledged by healthcare data experts, provides both consulting services and artificial intelligence-based software applications to healthcare providers and payers, including hospitals and health care systems, insurance and pharmaceutical companies, government and self-insured companies, to assist in the measurement of disease severity and patient financial and clinical outcomes. A pioneer in the development of data mining techniques that measure and predict outcomes, MEDai's processes produce results with accuracy beyond that of all other commercial methodologies. MEDai's leading-edge technology and services are aimed at meeting some of the most pressing information needs of today's dynamic health care delivery systems. The company's Web site address is www.medai.com.

About Clinteligent

Clinteligent is an application services provider (ASP) that delivers a complete clinical information system (CIS) solution to healthcare organizations. Clinteligent's services leverage advanced communications technologies (such as the Internet and virtual private networks) to lower the cost of clinical computing and transcend geographic boundaries. Clinteligent receives its strong foundation of applications from its parent company, CliniComp International, which has been successfully delivering clinical information systems since 1985 to customers such Ohio State University, Sharp Healthcare and the Department of Defense. The company's Web site address is www.clinteligent.com.